倾向匹配比较:电视辅助胸腔镜与开胸肺叶切除治疗局部晚期非小细胞肺癌
本研究通过倾向匹配分析比较了电视辅助胸腔镜肺叶切除与开胸肺叶切除在临床II期和IIIA期非小细胞肺癌患者中的围手术期结果和长期生存。匹配后每组120例,胸腔镜组住院时间更短(9.2 vs 12天,P=.014),并发症发生率相似,5年无病生存率和总生存率两组无显著差异。结论认为,在技术熟练的前提下,胸腔镜肺叶切除可用于多数局部晚期非小细胞肺癌病例而不影响围手术期结果和肿瘤学疗效。
要点
- 胸腔镜肺叶切除组住院时间显著短于开胸组(9.2 vs 12天,P=.014)。
- 两组术后并发症发生率相似(25% vs 28.3%,P=.56)。
- 5年无病生存率和总生存率两组无显著差异。
核心结论
- 在技术熟练和优化技术下,电视辅助胸腔镜肺叶切除可用于多数局部晚期非小细胞肺癌病例,不损害围手术期结果和肿瘤学疗效。
研究设计与样本
- 回顾性队列研究,纳入临床II期和IIIA期非小细胞肺癌接受肺叶切除的患者,采用倾向性评分匹配比较胸腔镜组(Wang技术)与开胸组,匹配后每组120例。
主要发现
- 胸腔镜组中转开胸率为11.7%。
- 胸腔镜组住院时间短于开胸组(9.2 vs 12天;P = .014)。
- 术后并发症发生率两组相似(30/125 [25%] vs 34/125 [28.3%];P = .56)。
- 5年无病生存率(49.1% vs 42.2%;P = .40)和总生存率(55.0% vs 57.1%;P = .73)两组相似。
- 多因素Cox回归显示,晚期病理分期(HR 2.018;95% CI 1.330-3.062)和无术后化疗(HR 1.880;95% CI 1.236-2.858)与死亡风险增加独立相关,而胸腔镜肺叶切除不是(HR 1.075;95% CI 0.714-1.620;P = .73)。
临床怎么用
- 对于临床II期和IIIA期非小细胞肺癌,在技术熟练的术者操作下,可考虑将胸腔镜肺叶切除作为开胸手术的替代选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated whether video-assisted thoracoscopic lobectomy for locally advanced non-small cell lung cancer could be performed safely and with acceptable long-term outcomes by our improved technique and compared with standard thoracotomy lobectomy in a well-balanced population. METHODS: Patients with clinical stage II and III A non-small cell lung cancers who received lobectomy were reviewed. Video-assisted thoracoscopic lobectomies were all performed with Wang's technique by the surgeons who had overcome the learning curve and achieved proficiency. By using propensity-matched analysis, perioperative outcomes and long-term survival were compared. RESULTS: Matching based on propensity scores produced 120 patients in each group. Conversion rate to thoracotomy was 11.7%. After thoracoscopic lobectomy, hospital length of stay was shorter compared with thoracotomy (9.2 vs 12 days; P = .014) despite similar rates of postoperative complications (30/125 [25%] vs 34/125 [28.3%]; P = .56). Disease-free survival (49.1% vs 42.2%; P = .40) and overall survival (55.0% vs 57.1%; P = .73) at 5 years were similar between groups. Although advanced pathologic stage (hazard ratio [HR], 2.018; 95% confidence interval [CI], 1.330-3.062) and no postoperative chemotherapy (HR, 1.880; 95% CI, 1.236-2.858) were independently associated with increased hazard of death in multivariable Cox regression at each time point in follow-up, thoracoscopic lobectomy was not (HR, 1.075; 95% CI, 0.714-1.620; P = .73). CONCLUSIONS: With continued experience and optimized technique, video-assisted thoracoscopic lobectomy can be performed in the majority of cases without compromising perioperative outcomes and oncologic efficacy.
引用
- Chen K, Wang X, Yang F, et al. Propensity-matched comparison of video-assisted thoracoscopic with thoracotomy lobectomy for locally advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016. PMID: 28088426. doi:10.1016/j.jtcvs.2016.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。